Egypt vs Syrian Arab Republic: HIV-positive TB patients on ART (antiretroviral therapy)
Egypt
100.0%
in 2024
Syrian Arab Republic
100.0%
in 2021
Egypt rank
1st
Syrian Arab Republic rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Egypt
- Syrian Arab Republic
How they compare
Egypt currently reports 100.0% against 100.0% in Syrian Arab Republic, a difference of 0.0%.
Across all 11 years both countries report, Syrian Arab Republic has been ahead every year.
Egypt ranks 1st and Syrian Arab Republic ranks 1st of 144 countries.
Head to head by decade
| Decade | Egypt | Syrian Arab Republic | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 100.0% | 0.0% | — |
| 2010s | 100.0% | 100.0% | 0.0% | — |
| 2020s | 100.0% | 100.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Egypt or Syrian Arab Republic?
- Egypt, at 100.0% against 100.0% in Syrian Arab Republic as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Egypt and Syrian Arab Republic?
- 0.0%, with Egypt ahead.
- How many years of comparable data are there for Egypt and Syrian Arab Republic?
- 11 years are reported by both, from 2007 to 2021.
- How do Egypt and Syrian Arab Republic rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Egypt ranks 1st and Syrian Arab Republic ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.